Colgate-Palmolive (NYSE:CL) Shares Sold by Boyd Watterson Asset Management LLC OH

Boyd Watterson Asset Management LLC OH decreased its stake in Colgate-Palmolive (NYSE:CLFree Report) by 17.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,500 shares of the company’s stock after selling 325 shares during the period. Boyd Watterson Asset Management LLC OH’s holdings in Colgate-Palmolive were worth $120,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Vest Financial LLC raised its position in Colgate-Palmolive by 25.1% in the 4th quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock valued at $29,498,000 after purchasing an additional 74,337 shares during the last quarter. Central Bank & Trust Co. raised its position in Colgate-Palmolive by 22.1% during the 4th quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock worth $110,000 after buying an additional 250 shares during the last quarter. Dynamic Advisor Solutions LLC raised its position in Colgate-Palmolive by 9.2% during the 4th quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock worth $864,000 after buying an additional 910 shares during the last quarter. Sarasin & Partners LLP raised its position in Colgate-Palmolive by 1.2% during the 4th quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock worth $323,115,000 after buying an additional 49,980 shares during the last quarter. Finally, Cornerstone Wealth Management LLC raised its position in Colgate-Palmolive by 2.5% during the 4th quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock worth $571,000 after buying an additional 172 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Barclays upped their price objective on shares of Colgate-Palmolive from $82.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Friday, April 12th. Evercore ISI upped their price objective on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research report on Monday, April 8th. The Goldman Sachs Group began coverage on shares of Colgate-Palmolive in a report on Friday, March 1st. They issued a “buy” rating and a $93.00 price target for the company. Raymond James upgraded shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target for the company in a report on Monday, January 29th. Finally, StockNews.com downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $89.50.

Check Out Our Latest Stock Analysis on Colgate-Palmolive

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, Director C Martin Harris sold 2,760 shares of the business’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the sale, the director now directly owns 19,272 shares in the company, valued at $1,628,484. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Colgate-Palmolive news, Director C Martin Harris sold 2,760 shares of the business’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the sale, the director now directly owns 19,272 shares in the company, valued at $1,628,484. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Noel R. Wallace sold 69,948 shares of the company’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the sale, the chief executive officer now directly owns 286,881 shares of the company’s stock, valued at $24,161,117.82. The disclosure for this sale can be found here. Insiders have sold a total of 232,371 shares of company stock worth $19,505,099 over the last ninety days. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock traded up $1.72 during mid-day trading on Friday, reaching $91.01. The company’s stock had a trading volume of 7,541,541 shares, compared to its average volume of 3,968,951. Colgate-Palmolive has a twelve month low of $67.62 and a twelve month high of $92.25. The firm has a market cap of $74.81 billion, a price-to-earnings ratio of 32.74, a PEG ratio of 3.35 and a beta of 0.42. The company has a current ratio of 1.11, a quick ratio of 0.71 and a debt-to-equity ratio of 8.59. The business has a 50 day moving average price of $87.66 and a 200-day moving average price of $81.46.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The company had revenue of $5.07 billion during the quarter, compared to the consensus estimate of $4.96 billion. During the same quarter in the previous year, the company posted $0.73 earnings per share. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. Sell-side analysts predict that Colgate-Palmolive will post 3.5 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be paid a dividend of $0.50 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.20%. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive’s payout ratio is currently 71.94%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.